{ "cik": 1787306, "cik_padded": "0001787306", "entityName": "Arcutis Biotherapeutics, Inc.", "fiscal_years": [ { "accn": "0001787306-26-000018", "filed": "2026-02-25", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 686000.0, "cash": 42907000.0, "eps_diluted": -0.13, "free_cash_flow": -6311000.0, "net_income": -16141000.0, "operating_cash_flow": -5625000.0, "operating_income": -12227000.0, "revenue": 376072000.0, "stockholders_equity": 189479000.0, "total_assets": 432973000.0, "total_liabilities": 243494000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.285071168836652, "net_margin": -0.042919972771171475, "operating_margin": -0.032512391244229825, "revenue_growth_yoy": 0.9134434370261827, "roa_avg2y": -0.041288616149653005, "roa_period_end": -0.03727946084397872, "roe_avg2y": -0.09302633853956545, "roe_period_end": -0.08518622116435066 } }, { "accn": "0001787306-26-000018", "filed": "2026-02-25", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 143000.0, "cash": 71335000.0, "eps_diluted": -1.16, "free_cash_flow": -112301000.0, "net_income": -140039000.0, "operating_cash_flow": -112158000.0, "operating_income": -128397000.0, "revenue": 196542000.0, "stockholders_equity": 157541000.0, "total_assets": 348889000.0, "total_liabilities": 191348000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.2145917570664144, "net_margin": -0.7125143735181284, "operating_margin": -0.6532802149158958, "revenue_growth_yoy": 2.297352615508506, "roa_avg2y": -0.4057607779165351, "roa_period_end": -0.4013855409600188, "roe_avg2y": -1.137566610345724, "roe_period_end": -0.8889051104157013 } }, { "accn": "0001787306-26-000018", "filed": "2026-02-25", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 428000.0, "cash": 88395000.0, "eps_diluted": -3.78, "free_cash_flow": -247485000.0, "net_income": -262140000.0, "operating_cash_flow": -247057000.0, "operating_income": -241101000.0, "revenue": 59606000.0, "stockholders_equity": 88667000.0, "total_assets": 341365000.0, "total_liabilities": 252698000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.8499667294483855, "revenue_growth_yoy": 15.170916983179598, "roa_avg2y": -0.6631092066037724, "roa_period_end": -0.7679170389465821, "roe_avg2y": -1.7578659370725034, "roe_period_end": -2.9564550509208614 } }, { "accn": "0001787306-26-000018", "filed": "2026-02-25", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 333000.0, "cash": 53641000.0, "eps_diluted": -5.66, "free_cash_flow": -258048000.0, "net_income": -311458000.0, "operating_cash_flow": -257715000.0, "operating_income": -301627000.0, "revenue": 3686000.0, "stockholders_equity": 209581000.0, "total_assets": 449274000.0, "total_liabilities": 239693000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1436771463062014, "roa_avg2y": -0.7264953477034752, "roa_period_end": -0.6932473279112524, "roe_avg2y": -1.228006261113674, "roe_period_end": -1.486098453581193 } }, { "accn": "0001787306-25-000029", "filed": "2025-02-25", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 995000.0, "cash": 96449000.0, "eps_diluted": -4.18, "free_cash_flow": -175622000.0, "net_income": -206356000.0, "operating_cash_flow": -174627000.0, "operating_income": -206529000.0, "stockholders_equity": 297677000.0, "total_assets": 408152000.0, "total_liabilities": 110475000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3711237347863624, "roa_avg2y": -0.5842295175256681, "roa_period_end": -0.5055861541778554, "roe_avg2y": -0.7262246215893774, "roe_period_end": -0.6932211759726146 } }, { "accn": "0001787306-24-000031", "filed": "2024-02-27", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 321000.0, "cash": 65082000.0, "eps_diluted": -3.8, "free_cash_flow": -113354000.0, "net_income": -135678000.0, "operating_cash_flow": -113033000.0, "operating_income": -136645000.0, "stockholders_equity": 270621000.0, "total_assets": 298269000.0, "total_liabilities": 27648000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1021650204529582, "roa_avg2y": -0.6695502626572675, "roa_period_end": -0.45488468463031695, "roe_avg2y": -1.319876259776645, "roe_period_end": -0.5013579877393107 } }, { "accn": "0001787306-23-000023", "filed": "2023-02-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 295000.0, "cash": 63336000.0, "eps_diluted": -22.78, "free_cash_flow": -43131000.0, "net_income": -41996000.0, "operating_cash_flow": -42836000.0, "operating_income": -43132000.0, "stockholders_equity": -65029000.0, "total_assets": 107012000.0, "total_liabilities": 5550000.0 }, "period_end": "2019-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_period_end": -0.39244196912495793, "roe_avg2y": 0.9435607081872922 } }, { "accn": "0001787306-22-000009", "filed": "2022-02-22", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 0.0, "free_cash_flow": -14085000.0, "net_income": -19255000.0, "operating_cash_flow": -14085000.0, "operating_income": -19735000.0, "stockholders_equity": -23987000.0 }, "period_end": "2018-12-31", "ratio_units": { "roe_avg2y": "ratio" }, "ratios": { "roe_avg2y": 1.3288474810213942 } }, { "accn": "0001628280-21-002272", "filed": "2021-02-16", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -4993000.0 }, "period_end": "2017-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001787306-26-000018", "filed": "2026-02-25", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001787306.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001787306.json" }, "ticker": "ARQT" }